VILLA, MATTEO
 Distribuzione geografica
Continente #
AS - Asia 1.582
EU - Europa 1.381
NA - Nord America 1.292
SA - Sud America 292
AF - Africa 36
OC - Oceania 5
Totale 4.588
Nazione #
US - Stati Uniti d'America 1.244
IT - Italia 617
SG - Singapore 539
VN - Vietnam 350
CN - Cina 317
BR - Brasile 236
RU - Federazione Russa 193
DE - Germania 146
HK - Hong Kong 144
IE - Irlanda 77
FR - Francia 59
GB - Regno Unito 59
SE - Svezia 59
KR - Corea 47
ID - Indonesia 41
IN - India 38
FI - Finlandia 35
NL - Olanda 31
PL - Polonia 25
AT - Austria 23
CA - Canada 23
AR - Argentina 19
JP - Giappone 17
MX - Messico 17
BD - Bangladesh 14
ZA - Sudafrica 14
EC - Ecuador 13
TR - Turchia 13
ES - Italia 10
IQ - Iraq 10
LT - Lituania 10
PH - Filippine 10
UA - Ucraina 8
BE - Belgio 7
PE - Perù 7
PK - Pakistan 7
KE - Kenya 6
MA - Marocco 6
CH - Svizzera 5
IR - Iran 5
VE - Venezuela 5
CL - Cile 4
EG - Egitto 4
TH - Thailandia 4
AZ - Azerbaigian 3
MY - Malesia 3
NP - Nepal 3
PY - Paraguay 3
TW - Taiwan 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CO - Colombia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ET - Etiopia 2
JO - Giordania 2
KZ - Kazakistan 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
RO - Romania 2
SA - Arabia Saudita 2
SV - El Salvador 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GR - Grecia 1
IL - Israele 1
KG - Kirghizistan 1
LY - Libia 1
MD - Moldavia 1
PA - Panama 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 4.588
Città #
Singapore 304
Milan 236
Ashburn 229
Dallas 183
Hong Kong 141
Ho Chi Minh City 113
Hefei 99
Ann Arbor 96
Hanoi 95
Dublin 75
Frankfurt am Main 75
New York 67
Los Angeles 64
Beijing 61
Seoul 43
Santa Clara 37
Munich 35
Jakarta 34
Chandler 33
Moscow 24
Buffalo 23
São Paulo 23
Desio 22
Rome 21
Fairfield 20
The Dalles 20
Chicago 19
Kent 19
Warsaw 17
Monza 16
Tokyo 16
Turku 16
Carate Brianza 15
Haiphong 14
Helsinki 14
London 14
Nuremberg 14
Stockholm 13
Shanghai 12
Chennai 11
Montreal 11
Rio de Janeiro 11
Da Nang 10
Denver 10
Genoa 10
Houston 10
Johannesburg 10
Lissone 10
Poplar 10
Vienna 10
Amsterdam 9
Ha Long 9
Orem 9
Paris 9
Perugia 9
Biên Hòa 8
Quezon City 8
Turin 8
Ankara 7
Atlanta 7
Boston 7
Brooklyn 7
Brussels 7
Campinas 7
Can Tho 7
Cesano Maderno 7
Ithaca 7
Lima 7
San Diego 7
Seattle 7
Seregno 7
Wilmington 7
Corsico 6
Lodz 6
Magenta 6
Manchester 6
Phoenix 6
Princeton 6
Querétaro 6
Quận Bình Thạnh 6
Quận Một 6
Romola 6
Baghdad 5
Curitiba 5
Hải Dương 5
Lappeenranta 5
Lauterbourg 5
Marano di Napoli 5
Mexico City 5
Peschiera Borromeo 5
Pune 5
Ribeirão Preto 5
Sesto San Giovanni 5
Seveso 5
Thái Nguyên 5
Toronto 5
Assago 4
Bangkok 4
Bergamo 4
Cagliari 4
Totale 2.798
Nome #
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 352
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 347
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 297
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 269
Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers 262
Investigation of drug resistance and co-mutational landscape of ALK-positive tumors 259
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 228
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 216
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 215
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 212
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering 208
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 200
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 185
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 185
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 184
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 181
New advances in liquid biopsy technologies for anaplastic lymphoma kinase (Alk)—positive cancer 175
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors 169
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 143
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 134
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer 130
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 100
Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) 32
Totale 4.683
Categoria #
all - tutte 14.112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.112


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 12 13 10 8 4 6 6
2021/202269 5 6 4 4 10 5 8 3 7 6 3 8
2022/2023221 20 34 17 17 8 15 1 9 20 33 22 25
2023/2024477 41 22 22 20 59 94 73 16 34 23 30 43
2024/20251.551 52 94 88 78 105 58 98 43 181 255 156 343
2025/20262.222 485 322 402 496 365 152 0 0 0 0 0 0
Totale 4.683